IPP Bureau
.jpg "Glenmark and IADVL undertake awareness campaign supporting vitiligo patients in India")
Glenmark and IADVL undertake awareness campaign supporting vitiligo patients in India
By IPP Bureau - June 27, 2024
Glenmark released Picture Post Cards on World Vitiligo Day
Aster DM Healthcare achieves NABH Digital Standards' Platinum Certification for Aster CMI Hospital
By IPP Bureau - June 27, 2024
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
Shilpa Medicare Bio Analytical unit gets "No Action Indicated" classification from USFDA
By IPP Bureau - June 27, 2024
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
CCRAS hosts national consultative meet on traditional medicine
By IPP Bureau - June 26, 2024
Signs MoUs with Shri Krishna Ayush University and Dabur India
Tagrisso with the addition of chemotherapy approved in Japan as new 1st-line treatment for patients with EGFR-mutated advanced lung cancer
By IPP Bureau - June 26, 2024
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care
Imfinzi improved event-free survival and overall survival for bladder cancer
By IPP Bureau - June 26, 2024
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
USDA approves Merck Animal Health’s NOBIVAC NXT canine flu H3N2
By IPP Bureau - June 26, 2024
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Lupin receives EIR from US FDA for its Somerset manufacturing facility
By IPP Bureau - June 25, 2024
The facility was inspected from May 7 to May 17, 2024
GlaxoSmithKline Pharmaceuticals appoints GoApptiv as super stockist
By IPP Bureau - June 25, 2024
This tie-up will have no impact on any other brands of the company
Venus Remedies clinches WHO-backed PAHO tender
By IPP Bureau - June 25, 2024
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
Sun Pharma’s Utreglutide demonstrates significant weight loss at the American Diabetes Association 84th Scientific Sessions
By IPP Bureau - June 25, 2024
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Sun Pharma completes Taro merger
By IPP Bureau - June 25, 2024
Combined entity is better positioned to compete in increasingly competitive generics industry
Arkema grants technology license to Seqens to manufacture PEKK for sale in medical implantable applications
By IPP Bureau - June 25, 2024
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Ascentage Pharma closes US$ 75 million equity investment by Takeda
By IPP Bureau - June 24, 2024
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
MediPharm Labs acquires advanced medical cannabis delivery method technology from Remidose Aerosols
By IPP Bureau - June 24, 2024
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
